Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease "HOPE-2"

Completed

Phase N/A Results

Summary of Purpose

To determine if lower homocysteine levels (lowered by folic acid, and vitamins B6 and B12) are associated with lower rates of coronary heart disease and stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 March 2009.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Canadian Institutes of Health Research Grant, Jamieson Laboratories, Canada

Trial Design

Randomized, double-blind, placebo controlled trial.

Contacts

Not available